Fibrosis: from mechanisms to medicines
1.1K
TL;DR: The transformative experimental strategies that are being leveraged to dissect the key cellular and molecular mechanisms that regulate fibrosis, and the translational approaches that are enabling the emergence of precision medicine-based therapies for patients with fibrosis are discussed.
read more
Abstract: Fibrosis can affect any organ and is responsible for up to 45% of all deaths in the industrialized world. It has long been thought to be relentlessly progressive and irreversible, but both preclinical models and clinical trials in various organ systems have shown that fibrosis is a highly dynamic process. This has clear implications for therapeutic interventions that are designed to capitalize on this inherent plasticity. However, despite substantial progress in our understanding of the pathobiology of fibrosis, a translational gap remains between the identification of putative antifibrotic targets and conversion of this knowledge into effective treatments in humans. Here we discuss the transformative experimental strategies that are being leveraged to dissect the key cellular and molecular mechanisms that regulate fibrosis, and the translational approaches that are enabling the emergence of precision medicine-based therapies for patients with fibrosis.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
CAR T cells produced in vivo to treat cardiac injury
Joel G. Rurik,István Tombácz,Amir Yadegari,Pedro O. Méndez Fernández,Swapnil V. Shewale,Li Li,Toru Kimura,Ousamah Younoss Soliman,Tyler E. Papp,Ying K. Tam,Barbara L. Mui,Steven M. Albelda,Ellen Puré,Carl H. June,Haig Aghajanian,Drew Weissman,Hamideh Parhiz,Jonathan I. Epstein +17 more
TL;DR: A therapeutic approach to generate transient antifibrotic chimeric antigen receptor (CAR) T cells in vivo by delivering modified messenger RNA (mRNA) in T cell–targeted lipid nanoparticles (LNPs) was developed.
726
Targeting integrin pathways: mechanisms and advances in therapy
Xiaocong Pang,Xu Dong He,Zhiwei Qiu,Hanxu Zhang,Ran Xie,Zhiyan Liu,Yanlun Gu,Nan Zhao,Qian Xiang,Yimin Cui +9 more
TL;DR: There are approximately 90 kinds of integrin-based therapeutic drugs or imaging agents in clinical studies, including small molecules, antibodies, synthetic mimic peptides, antibody-drug conjugates (ADCs), chimeric antigen receptor (CAR) T-cell therapy, imaging agents, etc as discussed by the authors .
Fibroblasts as immune regulators in infection, inflammation and cancer
Sarah Davidson,Mark Coles,Tom Thomas,George Kollias,Burkhard Ludewig,Burkhard Ludewig,Shannon J. Turley,Michael B. Brenner,Christopher D. Buckley,Christopher D. Buckley +9 more
TL;DR: In this article, the authors compare the mechanisms by which fibroblasts control local immune responses, as well as the factors regulating their inflammatory and suppressive profiles, in different tissues and pathological settings.
The spectrum of inflammatory responses
TL;DR: In animal biology, inflammatory response is an integral part of animal biology and provides critical protection from adverse environmental factors by enforcing the defense of homeostasis and the functional and structural inte...
Wound healing, fibroblast heterogeneity, and fibrosis.
TL;DR: Fibroblasts are highly dynamic cells that play a central role in tissue repair and fibrosis, and the mechanisms by which they contribute to both physiologic and pathologic states of extracellular matrix deposition and remodeling are just starting to be understood as mentioned in this paper .
301
References
Targeting Metabolism for Cancer Therapy
TL;DR: Current understanding of cancer metabolism is reviewed and how this might guide treatments targeting the metabolic requirements of tumor cells are discussed.
840
Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches
Svetoslav Chakarov,Hwee Ying Lim,Leonard Tan,Sheau Yng Lim,Peter See,Josephine Lum,Xiao Meng Zhang,Shihui Foo,Satoshi Nakamizo,Kaibo Duan,Wan Ting Kong,Rebecca Gentek,Akhila Balachander,Daniel Carbajo,Camille Bleriot,Benoit Malleret,Benoit Malleret,John Kit Chung Tam,Sonia Baig,Muhammad Shabeer,Sue-Anne Ee Shiow Toh,Andreas Schlitzer,Anis Larbi,Thomas Marichal,Bernard Malissen,Jinmiao Chen,Michael Poidinger,Kenji Kabashima,Kenji Kabashima,Marc Bajénoff,Lai Guan Ng,Veronique Angeli,Florent Ginhoux +32 more
TL;DR: In this article, two independent resident tissue macrophages (RTMs) populations are identified across tissues with specific niche-dependent phenotype and functional programming, and they are slowly replaced by Ly6Chi monocytes.
834
Multiplexed quantification of proteins and transcripts in single cells
Vanessa M. Peterson,Kelvin Xi Zhang,Namit Kumar,Jerelyn Wong,Lixia Li,Douglas C. Wilson,Renee Moore,Terrill K. McClanahan,Svetlana Sadekova,Joel A. Klappenbach +9 more
TL;DR: Using the RNA expression and protein sequencing assay (REAP-seq), the costimulatory effects of a CD27 agonist on human CD8+ lymphocytes and to identify and characterize an unknown cell type are assessed.
826
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
Neil C. Henderson,Thomas D. Arnold,Yoshio Katamura,Marilyn M. Giacomini,Juan D Rodriguez,Joseph H. McCarty,Antonella Pellicoro,Elisabeth Raschperger,Elisabeth Raschperger,Christer Betsholtz,Christer Betsholtz,Peter G. Ruminski,David W. Griggs,Michael J. Prinsen,Jacquelyn J. Maher,John P. Iredale,Adam Lacy-Hulbert,Ralf H. Adams,Dean Sheppard +18 more
TL;DR: Pdgfrb-Cre effectively targeted myofibroblasts in multiple organs, and depletion of the αv integrin subunit using this system was protective in other models of organ fibrosis, including pulmonary and renal fibrosis.
The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent activation of TGF-β1
Dezhi Mu,Stephanie Cambier,Stephanie Cambier,Lars Fjellbirkeland,Lars Fjellbirkeland,Jody L. Baron,John S. Munger,Hisaaki Kawakatsu,Dean Sheppard,Dean Sheppard,V. Courtney Broaddus,V. Courtney Broaddus,Stephen L. Nishimura,Stephen L. Nishimura +13 more
TL;DR: It is shown that SLC binds to αvβ8, an integrin expressed by normal epithelial and neuronal cells in vivo, which results in the membrane type 1 (MT1)-MMP–dependent release of active TGF-β, which leads to autocrine and paracrine effects on cell growth and matrix production.